Oric Pharmaceuticals share price logo

Oric Pharmaceuticals

NASDAQ: ORIC

Small Cap

$7.86

-0.64

(-7.53%)

as on

Oric Pharmaceuticals Stock Performance

as on November 14, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $7.84
    $8.67
    downward going graph

    0.25%

    Downside

    10.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.23
    $14.68
    downward going graph

    8.02%

    Downside

    86.77%

    Upside

    downward going graph

Oric Pharmaceuticals share price movements today

Previous Close
$8.50
Open
$8.50
Volume
725.4K
Market Cap
$881.0M
Day's Low - High
$7.84 - $8.67
52 Week Low - High
$7.23 - $14.68

Oric Pharmaceuticals Historical Returns

1 Month Return
-32.18 %
3 Month Return
-43.33 %
1 Year Return
-35.84 %
3 Year Return
+ 15.93 %
5 Year Return
-55.39 %

Oric Pharmaceuticals Stock Fundamentals & Key Indicators

Check Oric Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$881.0M

EPS (TTM)

-1.35

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.32

Industry PE ratio

-6.17

PEG Ratio

-0.18

EBITDA

-143.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-35.35%

Oric Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oric Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$881.0M-55.39%-6.320.00%0.00%
Neutral$100.6B0.07%-35.1828.00%0.00%
StrongBuy$47.5BNA68.7388.39%0.00%
StrongBuy$137.6B187.58%34.7885.57%0.00%
Buy$99.2B51.37%20.2985.77%0.39%

Stock Returns calculator for Oric Pharmaceuticals Stock including INR - Dollar returns

The Oric Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Oric Pharmaceuticals investment value today

Current value as on today

₹68,179

Returns

-₹31,821

(-31.82%)

Returns from Oric Pharmaceuticals Stock

-₹35,837 (-35.84%)

Dollar Impact

₹4,016 (+4.02%)

Analyst Recommendation on Oric Pharmaceuticals Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Oric Pharmaceuticals. Average target price of $21.71

Oric Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Oric Pharmaceuticals.

What analysts predicted

63.8%UPSIDE

Target Price

$21.71

Current Price

$7.86

Analyzed by

7 Analysts

High

$27

Target

$21.71

Low

$18

Oric Pharmaceuticals target price $21.71, a slight upside of 63.8% compared to current price of $7.86. According to 7 analysts rating.

Indian Investors' Interest in Oric Pharmaceuticals Stock

Search interest for Oric Pharmaceuticals Stock has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:63% versus previous 30 day period

Oric Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
0
-
-
-
0
-
0
Operating Income
-28
-36
-38
-39
-32
-39
-36
-34
-39
-45
EBITDA
-24
-31
-34
-36
-29
-36
-32
-30
-35
-45
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-25
-31
-34
-36
-30
-36
-32
-30
-35
-41
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-25
-31
-34
-36
-30
-36
-32
-30
-35
-41
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Oric Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-1
-
-
-
-1
-1
-1
Operating Income
-22
-22
-28
-74
-78
-91
-110
-142
-143
EBITDA
-21
-21
-25
-48
-77
-85
-99
-126
-128
Interest Expense
-
-
-
-
-
2
-
-
-
Depreciation
0
0
1
0
0
0
1
1
1
Income Before Tax
-22
-21
-26
-73
-78
-89
-100
-127
-129
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-22
-21
-26
-73
-78
-89
-100
-127
-129
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Oric Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-25
-31
-34
-36
-30
-36
-32
-30
-35
-41
Operating Cash Flow
-30
-25
-28
-28
-32
-30
-25
-22
-32
-31
Investing Cash Flow
-61
18
23
42
22
-76
-110
16
-17
11
Financing Cash Flow
125
0
0
0
0
134
109
1
61
0
Change in Cash
32
-6
-5
15
-10
26
-26
-3
10
-18

Oric Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-22
-21
-26
-73
-78
-89
-100
-127
-129
Operating Cash Flow
-20
-20
-23
-45
-59
-75
-85
-112
-110
Investing Cash Flow
0
0
0
-215
158
-109
-43
22
-148
Financing Cash Flow
0
38
70
250
49
25
85
126
245
Change in Cash
-20
16
46
-10
148
-159
-43
36
-13

Global Institutional Holdings in Oric Pharmaceuticals

Check out the Institutions with significant holdings in Oric Pharmaceuticals.

Funds
Holdings
BlackRock, Inc.
6.58%
Andreas Halvorsen
4.95%
Vanguard
4.47%
VANGUARD INDEX FUNDS
3.73%
iShares
3.65%

Oric Pharmaceuticals News & Key Events

  • img

    Today's Timeline - 23 October

    Fri, 06:03 PM

    -

    Oric Pharmaceuticals presents strong enozertinib data, plans Phase 3 trial for EGFR atypical non-small cell lung cancer.

Insights on Oric Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 201.4% return, outperforming this stock by 185.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 801.8% return, outperforming this stock by 837.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ORIC stock has moved down by -32.2%

About Oric Pharmaceuticals

ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another candidate, ORIC-944, is an allosteric inhibitor targeting the polycomb repressive complex 2, specifically for the treatment of prostate cancer. Furthermore, ORIC-114 is a brain-penetrant, orally administered, irreversible inhibitor crafted to precisely target epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), demonstrating high potency against exon 20 insertion mutations. Beyond these advanced programs, ORIC Pharmaceuticals is also cultivating multiple early-stage precision medicines aimed at other mechanisms of cancer resistance. The company has established partnerships, including a licensing and collaboration agreement with Voronoi Inc., and a licensing agreement with Mirati Therapeutics, Inc. ORIC Pharmaceuticals was founded in 2014 and maintains its headquarters in South San Francisco, California.
OrganisationOric Pharmaceuticals
Headquarters240 East Grand Avenue, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEOJacob Chacko

Key Management of Oric Pharmaceuticals

Name

Title

Dr. Kevin Brodbeck Ph.D.

Chief Technical Officer

Dr. Lori Sickels Friedman Ph.D.

Chief Scientific Officer

Mr. Daniel Iazzetti

VP & Head of People

Dr. Charles L. Sawyers B.A., M.D., Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Jacob M. Chacko M.B.A., M.D.

President, CEO & Director

Mr. Dominic G. Piscitelli CPA, M.B.A.

Chief Financial Officer

Dr. Pratik S. Multani M.D., M.S.

Chief Medical Officer

Dr. Scott W. Lowe Ph.D.

Founder & Member of Scientific Advisory Board

Dr. Christian V. Kuhlen Esq., J.D., M.D.

General Counsel & Chief Compliance Officer

Dr. Richard A. Heyman Ph.D.

Founder, Independent Chairman & Member of Scientific Advisory Board

FAQs

What is Oric Pharmaceuticals share price today?

Oric Pharmaceuticals share price today is $7.86 as on at the close of the market. Oric Pharmaceuticals share today touched a day high of $8.67 and a low of $7.84.

What is the 52 week high and 52 week low for Oric Pharmaceuticals share?

Oric Pharmaceuticals share touched a 52 week high of $14.68 on and a 52 week low of $7.23 on . Oric Pharmaceuticals stock price today i.e. is closed at $7.86,which is 46.46% down from its 52 week high and 8.71% up from its 52 week low.

What is Oric Pharmaceuticals's market capitalisation today?

Oric Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Oric Pharmaceuticals Stock (ORIC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Oric Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Oric Pharmaceuticals Stock (ORIC) from India?

Indian investors can start investing in Oric Pharmaceuticals (ORIC) shares with as little as ₹94.23999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Oric Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Oric Pharmaceuticals share’s latest price of $7.86 as on November 14, 2026 at 8:45 am IST, you will get 1.2723 shares of Oric Pharmaceuticals. Learn more about fractional shares .

What are the returns that Oric Pharmaceuticals has given to Indian investors in the last 5 years?

Oric Pharmaceuticals stock has given -55.39% share price returns and 25.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?